Total Payments
$3,181
2024 Payments
$813.98
Companies
18
Transactions
70
Medicare Patients
2,496
Medicare Billing
$130,750
Payment Breakdown by Category
Food & Beverage$3,167 (99.6%)
Education$13.94 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,167 | 68 | 99.6% |
| Education | $13.94 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| HEARTFLOW, INC. | $775.57 | 12 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $346.22 | 10 | $0 (2021) |
| Cleerly, Inc. | $341.11 | 4 | $0 (2024) |
| Amgen Inc. | $271.18 | 8 | $0 (2019) |
| Inari Medical, Inc. | $248.57 | 1 | $0 (2022) |
| PFIZER INC. | $209.49 | 9 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $207.15 | 6 | $0 (2022) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $134.62 | 1 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $132.10 | 2 | $0 (2021) |
| Bayer Healthcare Pharmaceuticals Inc. | $120.38 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $813.98 | 9 | HEARTFLOW, INC. ($251.22) |
| 2023 | $467.61 | 7 | HeartFlow, Inc. ($308.57) |
| 2022 | $518.60 | 7 | Inari Medical, Inc. ($248.57) |
| 2021 | $138.82 | 3 | Actelion Pharmaceuticals US, Inc. ($107.42) |
| 2019 | $227.09 | 10 | PFIZER INC. ($144.73) |
| 2018 | $468.82 | 17 | E.R. Squibb & Sons, L.L.C. ($154.41) |
| 2017 | $545.71 | 17 | Novartis Pharmaceuticals Corporation ($265.75) |
All Payment Transactions
70 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $134.62 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/26/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $42.10 | General |
| Category: Coronary | ||||||
| 05/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $120.38 | General |
| Category: Cardio-renal | ||||||
| 05/22/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $86.40 | General |
| Category: Coronary | ||||||
| 05/22/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $86.39 | General |
| Category: Coronary | ||||||
| 03/04/2024 | Cleerly, Inc. | Cleerly Ischemia (Device), Cleerly Labs | Food and Beverage | In-kind items and services | $149.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/14/2024 | Cleerly, Inc. | Cleerly Ischemia (Device), Cleerly Labs | Food and Beverage | In-kind items and services | $51.80 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/08/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $36.33 | General |
| Category: Coronary | ||||||
| 01/24/2024 | GE HEALTHCARE | — | Food and Beverage | In-kind items and services | $106.68 | General |
| 12/20/2023 | HeartFlow, Inc. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $30.86 | General |
| Category: Coronary | ||||||
| 12/06/2023 | Cleerly, Inc. | Cleerly Labs (Device) | Food and Beverage | In-kind items and services | $98.92 | General |
| 11/07/2023 | Cleerly, Inc. | Cleerly Labs (Device) | Food and Beverage | In-kind items and services | $41.11 | General |
| 09/20/2023 | HeartFlow, Inc. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $42.06 | General |
| Category: Coronary | ||||||
| 08/30/2023 | HeartFlow, Inc. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $181.29 | General |
| Category: Coronary | ||||||
| 04/28/2023 | Canon Medical Systems USA, Inc. | CT SCANNER (Device) | Food and Beverage | Cash or cash equivalent | $19.01 | General |
| Category: TSX-306A | ||||||
| 02/15/2023 | HeartFlow, Inc. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $54.36 | General |
| Category: Coronary | ||||||
| 12/12/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.63 | General |
| Category: Cardiovascular | ||||||
| 09/22/2022 | HeartFlow, Inc. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $38.37 | General |
| Category: Coronary | ||||||
| 08/31/2022 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | In-kind items and services | $27.78 | General |
| Category: Cardiovascular | ||||||
| 08/09/2022 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $248.57 | General |
| Category: VTE | ||||||
| 06/01/2022 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $20.54 | General |
| Category: Cardiovascular | ||||||
| 04/27/2022 | HeartFlow, Inc. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $130.00 | General |
| Category: Coronary | ||||||
| 04/21/2022 | HeartFlow, Inc. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $33.71 | General |
| Category: Coronary | ||||||
| 11/03/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/15/2021 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT, BOSENTAN | Food and Beverage | In-kind items and services | $107.42 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 564 | 609 | $82,915 | $29,045 |
| 2022 | 11 | 761 | 830 | $119,189 | $40,830 |
| 2021 | 9 | 633 | 684 | $99,610 | $35,237 |
| 2020 | 11 | 538 | 556 | $73,739 | $25,638 |
Total Patients
2,496
Total Services
2,679
Medicare Billing
$130,750
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 64 | 86 | $17,780 | $9,365 | 52.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 156 | 158 | $33,259 | $8,672 | 26.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 32 | 38 | $5,820 | $2,866 | 49.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 23 | 36 | $5,778 | $2,177 | 37.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 13 | 13 | $3,815 | $1,902 | 49.9% |
| 75561 | Mri scan of heart before and after contrast | Facility | 2023 | 14 | 14 | $4,557 | $1,396 | 30.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 144 | 146 | $5,546 | $952.65 | 17.2% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 27 | 27 | $1,505 | $461.16 | 30.6% |
| 93272 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | Facility | 2023 | 22 | 22 | $1,326 | $428.78 | 32.3% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Facility | 2023 | 24 | 24 | $1,572 | $342.01 | 21.8% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 30 | 30 | $1,524 | $338.10 | 22.2% |
| 75565 | Mri scan of blood flow of heart | Facility | 2023 | 15 | 15 | $433.75 | $144.15 | 33.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 230 | 238 | $53,840 | $13,061 | 24.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 60 | 77 | $15,785 | $8,998 | 57.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 40 | 40 | $11,727 | $5,753 | 49.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 57 | 76 | $11,400 | $5,673 | 49.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 18 | 33 | $7,607 | $2,719 | 35.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 182 | 187 | $7,013 | $1,229 | 17.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 13 | 16 | $2,568 | $914.80 | 35.6% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2022 | 49 | 49 | $2,695 | $845.22 | 31.4% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Facility | 2022 | 40 | 41 | $2,665 | $589.39 | 22.1% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2022 | 49 | 49 | $2,450 | $564.12 | 23.0% |
| 93272 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | Facility | 2022 | 23 | 24 | $1,440 | $482.63 | 33.5% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2021 | 201 | 203 | $45,800 | $11,702 | 25.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 69 | 99 | $14,850 | $8,107 | 54.6% |
About Dr. Christopher Dyke, MD
Dr. Christopher Dyke, MD is a Cardiovascular Disease healthcare provider based in Denver, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1891704409.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Dyke, MD has received a total of $3,181 in payments from pharmaceutical and medical device companies, with $813.98 received in 2024. These payments were reported across 70 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($3,167).
As a Medicare-enrolled provider, Dyke has provided services to 2,496 Medicare beneficiaries, totaling 2,679 services with total Medicare billing of $130,750. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease
- Location Denver, CO
- Active Since 08/05/2006
- Last Updated 02/22/2021
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1891704409
Products in Payments
- FFRct (Device) $775.57
- ENTRESTO (Drug) $346.22
- ELIQUIS (Drug) $297.07
- FLOWTRIEVER CATHETER, S (Device) $248.57
- Repatha (Biological) $201.26
- Cleerly Ischemia (Device) $201.08
- Cleerly Labs (Device) $140.03
- LifeVest (Device) $134.62
- UPTRAVI (Drug) $132.10
- Kerendia (Drug) $120.38
- INVOKANA (Drug) $93.00
- Corlanor (Drug) $69.92
- CHANTIX (Drug) $63.06
- BRILINTA (Drug) $55.61
- LUTONIX (Device) $38.40
- VIAGRA (Drug) $35.97
- Optimizer (Device) $27.78
- XARELTO (Drug) $26.54
- CAMZYOS (Drug) $20.54
- CT SCANNER (Device) $19.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Denver
Dr. Andrew Freeman, Md, MD
Cardiovascular Disease — Payments: $477,895
Cardiovascular Disease $477,895
Matthew Holland, M.d, M.D
Cardiovascular Disease — Payments: $46,811
Cardiovascular Disease $46,811
Dr. Christopher Barrett, M.d, M.D
Cardiovascular Disease — Payments: $33,700
Cardiovascular Disease $33,700
Alexis Tumolo, M.d, M.D
Cardiovascular Disease — Payments: $32,631
Cardiovascular Disease $32,631
Glenn Hirsch, M.d, M.D
Cardiovascular Disease — Payments: $30,595
Cardiovascular Disease $30,595
Dr. Mori Krantz, Md, MD
Cardiovascular Disease — Payments: $22,589
Cardiovascular Disease $22,589